Cosentyx sensoready 150 MG penml
Ended Awarded
- Contract number
- SPE2DB26FXHGU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $174,109
Award facts
- Contract value 100% obligated
- $174,109.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $174,109.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx Sensoready 150 mg pens on October 27, 2025, with completion targeted for October 28, 2025. This competitive award, utilizing no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. Cosentyx is a biologic immunosuppressant medication used to treat inflammatory conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis, supporting the Defense Health Agency's pharmaceutical supply requirements for military personnel and beneficiaries.
This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen Drug Corp serves as a critical distributor for the Defense Logistics Agency's Medical Supply Chain, providing comprehensive pharmaceutical products and medical supplies to support military healthcare systems globally. The company's extensive portfolio of federal contracts demonstrates its established capability to fulfill competitive procurement requirements for specialized medications and medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FXHGU?
SPE2DB26FXHGU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FXHGU worth?
The government has obligated $174,109 on SPE2DB26FXHGU.
Is contract SPE2DB26FXHGU an order under another contract?
Yes. SPE2DB26FXHGU is a delivery order under SPE2DB25D3006, an indefinite delivery contract.
Was contract SPE2DB26FXHGU competed?
The extent of competition for SPE2DB26FXHGU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award